Contact Us

Vytorin
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

Date you started taking this drug:

Date you stopped taking this drug:

What condition was this medication prescribed to treat?

What Type of Incident Did You have (Heart Attack, Stroke, etc)

Incident Date 

How Long Were You On Vytorin Before The Incident Occured

If other, please explain: 

Did insurance cover your medication?

What was your total out of pocket expense?

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic

Vytorin

Vytorin, Zetia Disappoint Again

Nov 16, 2009
| Parker Waichman LLP
Vytorin and Zetia, Merck & Co.'s anti-cholesterol medications, are coming under fire again.  A new study has found that a much older - and...

Lawsuit Claims Execs Knew Vytorin Study Wouldn't Be Favorable

Oct 15, 2009
| Parker Waichman LLP
A lawsuit alleges that marketing executives at Schering-Plough, one of the makers of Vytorin, knew long before it was released that the ENHANCE study...

Vytorin Makers Spent Millions on Medical Education

Sep 15, 2009
| Parker Waichman LLP
Merck & Co. and Schering-Plough, the makers of Vytorin, spent millions over the past four years to educate doctors about  the latest...

No Proof Combo Pills Like Vytorin Work Better, Study Finds

Sep 3, 2009
| Parker Waichman LLP
A new study says there is no proof that combo cholesterol lowering drugs like Vytorin work better than high doses of statins.   Vytorin,...

Vytorin Makers Announce $41.5 Million Class Action Settlement

Aug 6, 2009
| Parker Waichman LLP
The makers of Vytorin are settling more lawsuits.  According to a Reuters report, Merck and Schering-Plough will pay $41.5 million to settle...

Vytorin Named in Another Lawsuit

Jun 9, 2009
| Parker Waichman LLP
Vytorin, the controversial cholesterol-lowering drug, has been named in yet another lawsuit.  According to Bloomberg.com, the Pennsylvania...

Vytorin Forum Postings Can Stay In Lawsuit, Judge Says

Jun 3, 2009
| Parker Waichman LLP
A judge in a Vytorin lawsuit has decided that some incriminating comments on an internet website frequented by pharmaceutical sales reps can be...

Vytorin Probe Seeks More Information

Feb 20, 2009
| Parker Waichman LLP
Lawmakers investigating the cholesterol drug Vytorin have asked Merck and Schering-Plough for more information on the medication's clinical...

Vytorin Named in 100+ Lawsuits, Justice Department Investigation

Dec 2, 2008
| Parker Waichman LLP
Nearly a year after an important Vytorin study raised serious doubts about its effectiveness, Merck and Schering-Plough are facing an increasing...

Experts Divided on Vytorin Cancer Risk

Nov 13, 2008
| Parker Waichman LLP
Vytorin was the subject of a heated debate at the annual meeting of the American Heart Association in New Orleans yesterday.  At issue was the...

Page 1/6 [first] [prev] 1 2 3 4 5 6 [next] [last]